Overview

Safety and Drug Absorption of Orally Administered Oleylphosphocholine (OlPC) in Healthy Adults

Status:
Terminated
Trial end date:
2024-02-27
Target enrollment:
Participant gender:
Summary
The goal of this interventional study is to assess the safety and tolerability of OlPC and to characterize the pharmacokinetics (PK) of OlPC following single, ascending doses administered orally in healthy-fed subjects.
Phase:
Phase 1
Details
Lead Sponsor:
University Hospital Tuebingen